1. Home
  2. FEDU vs AFMD Comparison

FEDU vs AFMD Comparison

Compare FEDU & AFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEDU
  • AFMD
  • Stock Information
  • Founded
  • FEDU 2007
  • AFMD 2000
  • Country
  • FEDU China
  • AFMD Germany
  • Employees
  • FEDU 190
  • AFMD N/A
  • Industry
  • FEDU
  • AFMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • FEDU
  • AFMD Health Care
  • Exchange
  • FEDU NYSE
  • AFMD Nasdaq
  • Market Cap
  • FEDU 22.2M
  • AFMD 17.5M
  • IPO Year
  • FEDU 2017
  • AFMD 2014
  • Fundamental
  • Price
  • FEDU $10.49
  • AFMD $1.15
  • Analyst Decision
  • FEDU
  • AFMD Strong Buy
  • Analyst Count
  • FEDU 0
  • AFMD 5
  • Target Price
  • FEDU N/A
  • AFMD $13.50
  • AVG Volume (30 Days)
  • FEDU 4.9K
  • AFMD 363.4K
  • Earning Date
  • FEDU 12-20-2024
  • AFMD 11-14-2024
  • Dividend Yield
  • FEDU 21.93%
  • AFMD N/A
  • EPS Growth
  • FEDU N/A
  • AFMD N/A
  • EPS
  • FEDU 0.12
  • AFMD N/A
  • Revenue
  • FEDU $27,971,139.00
  • AFMD $6,287,085.00
  • Revenue This Year
  • FEDU N/A
  • AFMD N/A
  • Revenue Next Year
  • FEDU N/A
  • AFMD $212.48
  • P/E Ratio
  • FEDU $88.02
  • AFMD N/A
  • Revenue Growth
  • FEDU 141.14
  • AFMD N/A
  • 52 Week Low
  • FEDU $7.41
  • AFMD $1.03
  • 52 Week High
  • FEDU $22.70
  • AFMD $8.95
  • Technical
  • Relative Strength Index (RSI)
  • FEDU 48.38
  • AFMD 28.57
  • Support Level
  • FEDU $10.15
  • AFMD $1.03
  • Resistance Level
  • FEDU $10.88
  • AFMD $1.41
  • Average True Range (ATR)
  • FEDU 0.59
  • AFMD 0.11
  • MACD
  • FEDU 0.10
  • AFMD 0.05
  • Stochastic Oscillator
  • FEDU 63.68
  • AFMD 23.53

About FEDU FOUR SEASONS EDUCATION (CAYMAN) INC SPON ADS EACH REP 10 ORD SHS(R/S)

Four Seasons Education (Cayman) Inc is engaged in the provision of after-school education services for kindergarten, elementary and middle school students. The Company derives its revenue from learning services, tourism services, and learning technology and content solutions. The company is a comprehensive educational enterprise that provides research practice services, educational informatization equipment, high-quality educational resources, and teacher training, as well as a digital publishing business, and continues to expand in educational research and educational informatization.

About AFMD Affimed N.V.

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.

Share on Social Networks: